Sign In

Scott Kollins

Psychologist, Digital health and data enthusiast, Views are my own

Professional Background

Dr. Scott Kollins is a distinguished clinical research and digital health executive, bringing a wealth of knowledge and expertise to the field. With a strong command over the digital health product lifecycle and extensive regulatory experience, Dr. Kollins has played a pivotal role in advancing innovative healthcare solutions. His career encompasses various leadership positions at renowned companies, including Chief Medical Officer roles at Aura, Akili Interactive, and Holmusk.

Dr. Kollins has not only excelled in industry but also boasts a prolific academic career, with over 20 years at Duke University School of Medicine. There, he was a tenured Professor in the Department of Psychiatry & Behavioral Sciences and currently holds an Adjunct Professor appointment. His connection to Duke extends to his involvement with the Duke Center for Girls & Women with ADHD and the Duke Clinical Research Institute, where he continues to provide invaluable guidance.

Education and Achievements

Dr. Kollins’ academic foundation is built on his studies at Auburn University, where he earned both his M.S. and Ph.D. in Clinical Psychology. Prior to that, he completed a Bachelor of Arts in Psychology at Duke University, establishing a robust educational background that underpin his career in clinical research and digital health.

Known as one of the nation’s leading experts in Attention-Deficit/Hyperactivity Disorder (ADHD), Dr. Kollins's research interests span a broad spectrum. His extensive work not only delves into ADHD across the lifespan but also human psychopharmacology, nicotine dependence, and substance use disorders. His scholarly contributions include publishing over 200 peer-reviewed scientific papers, solidifying his status as a preeminent contributor to scientific literature in these fields.

Noteworthy Contributions

Dr. Kollins’s impact in the clinical research arena is underscored by his role as a principal investigator on more than 60 industry-funded clinical trials. His commitment to advancing knowledge in his field has earned him membership in prestigious organizations such as the College on Problems of Drug Dependence, and he is a fellow of both the American College of Neuropsychopharmacology and the American Psychological Association Division 28, which focuses on Psychopharmacology and Substance Abuse.

In addition to his research and executive roles, Dr. Kollins has demonstrated significant service to the scientific community. He has acted as a reviewer for numerous U.S.-based and international granting agencies, and has served as an editor or referee for more than 50 peer-reviewed journals. His contributions reflect a commitment to maintaining high standards in research and encouraging the growth of scientific inquiry.

Achievements

  • Over 200 published scientific papers in peer-reviewed journals.
  • Principal investigator for more than 60 industry-funded clinical trials.
  • Elected member of the College on Problems of Drug Dependence.
  • Fellow of the American College of Neuropsychopharmacology.
  • Fellow of the American Psychological Association Division 28 (Psychopharmacology and Substance Abuse).
  • Licensed clinical psychologist in North Carolina.

Related Questions

How did Dr. Scott Kollins develop his expertise in ADHD research?
What regulations in the digital health product lifecycle is Dr. Scott Kollins most knowledgeable about?
In what ways has Dr. Scott Kollins contributed to advancements in psychopharmacology?
What key insights guide Dr. Scott Kollins in his role as a Chief Medical Officer?
How has Dr. Scott Kollins influenced the Duke Center for Girls & Women with ADHD?
Scott Kollins
Add to my network

Location

Raleigh-Durham-Chapel Hill Area